Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Depression is one of the most common psychiatric symptoms in Alzheimer’s disease (AD), and considerable evidence indicates that major depressive disorder increases the risk of AD. 1 , 2 , 3 To date, however, the molecular mechanisms underlying the clinical association between depression and AD have remained elusive. Soluble oligomers of the amyloid-β peptide (AβOs) accumulate in the brains of AD patients and are increasingly recognized as the proximal neurotoxins responsible for synapse failure and memory deficits in AD. 4 , 5 We have hypothesized that AβOs might be mechanistically linked to behavioral changes in AD. In order to test this hypothesis, mice were given a single intracerebroventricular (i.c.v.) injection of 10 pmol AβOs and were subsequently evaluated in the Porsolt forced swim test (FST) for assessment of depressive-like behavior. Compared with vehicle-injected control mice, AβO-injected mice exhibited a significant increase in immobility in the FST, both 24 h and 8 days after AβO injections ( Figure 1a ). Similar results were obtained when animals were assessed in the tail suspension test, another classical task to evaluate depressive-like behavior in rodents ( Supplementary Figure S1a ). AβO-induced immobility in the FST was blocked by anti-depressant (fluoxetine) treatment ( Figure 1a ). An important feature of depressive disorder is anhedonic behavior, including decreased interest for pleasurable sensorial experiences. Whereas vehicle-injected mice exhibited an expected preference for sucrose solution over plain water, AβO-injected mice did not exhibit such preference, indicating that AβOs instigate anhedonic behavior ( Figure 1b ). Figure 1 Amyloid-β oligomers (AβOs) induce depressive-like behavior, memory deficits and hippocampal recruitment of microglia and astrocytes in mice. Three-month-old Swiss mice received a single intracerebroventricular (i.c.v.) injection of AβOs (10 pmol) or vehicle, and were submitted to behavioral tests 24 h or 8 days after injection. ( a ) Immobility time (s) in the Porsolt forced swim test (FST) was measured for vehicle- and AβO-injected animals, treated with fluoxetine (Flx, 30 mg kg −1 ) or saline (Sal). Flx was administered 23 h, 5 h and 1 h before AβO injection. Bars represent means±s.e.m. * P <0.05, ** P <0.01; analysis of variance followed by post-hoc Newman–Keuls test ( n =7–10 mice per group). ( b ) Sucrose preference expressed as the ratio between the volumes of 2% sucrose solution or plain water consumed. Bars represent means±s.e.m. * P <0.05; Student’s one-sample t -test ( n =13–14 mice per group) compared with 1 (no preference). ( c ) Recognition memory was assessed using the novel object recognition (OR) task. The percentage of time spent exploring the old (familiar) or new (novel) objects was measured for animals injected with vehicle or AβOs, treated with Flx (10 mg kg −1 daily for 17 days) or saline (Sal). Bars represent means±s.e.m. * P <0.05, Student’s one-sample t -test ( n =8–11 mice per group). ( d , e ) Levels of pro-inflammatory cytokines (interleukin (IL)-1β and tumor necrosis factor (TNF)-α) in brain extracts from mice injected i.c.v. with AβOs or vehicle. Bars represent means±s.e.m. * P <0.05, ** P <0.01; Student’s t -test ( n =6–8 mice per group). ( f – o ) Microglia (Iba-1-positive cells) and astrocytes (GFAP-positive cells) in the hippocampus of mice injected i.c.v. with AβOs or vehicle, and treated with Sal or Flx. Scale bars=50 μm. Bars in panels j and o represent means±s.e.m. * P <0.05, *** P <0.001; analysis of variance followed by Bonferroni test ( n =3–6 mice per group). PowerPoint slide Full size image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.753 · Cited by 551
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442
Self-citationCirrito, J. R., Disabato, B. M., Restivo, J. L., Verges, D. K., Goebel, W. D., Sathyan, A., Hayreh, D., D'Angelo, G., Benzinger, T., Yoon, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107411108 · Cited by 377
Monoclonal antibodies that target pathological assemblies of Aβ
Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y., Bigio, E. H., Shaw, P., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04157.x · Cited by 314
Cited by
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935
Self-citationIs Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Significance of long chain polyunsaturated fatty acids in human health
Zárate, R., el Jaber‐Vazdekis, N., Tejera, N., Pérez, J. A., & Rodríguez, C. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0153-6 · Cited by 551
Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny-Germano, L., Batista, A. F., Sathler, L. B., Brito-Moreira, J., Amaral, O. B., Silva, C. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.002 · Cited by 420
Self-citationFerreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373
“Impaired insulin signaling and increased astrogliosis may further facilitate the production of pro-inflammatory cytokines in the brain, as suggested by several reports (Carrero et al., 2012; Ledo et al., 2013; Lourenco et al., 2013).”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., De Felice, F. G., & Ferreira, S. T.
- Venue
- Molecular Psychiatry
- Published
- 2012-11-27
- Volume
- 18
- Issue
- 10
- Pages
- 1053-1054
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2042751066
- Cited by
- 155
- References
- 8
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. https://app.cochat.ai/papers/10.1038/mp.2012.168
- The paper
- Ledo, J. H., Azevedo, E. P., Clarke, J. R., Ribeiro, F. C., Figueiredo, C. P., Foguel, D., De Felice, F. G., & Ferreira, S. T. (2013). Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. Molecular Psychiatry. https://doi.org/10.1038/mp.2012.168
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.